Evaluating migraine treatment designs
Part of Brain & nervous system, Pain clinical trials.
This trial is testing new ways to treat migraine attacks. It is for adults in Denmark who have migraine on a few days each month and have used triptan rescue medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You have had migraine (with or without aura) for at least one year, and it was diagnosed before age 50.
- You have 2 to 8 migraine days per month (episodic migraine).
- You have used triptans (migraine rescue medicines) before or currently.
- You can speak and read Danish (the study is conducted in Denmark).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a substance called CGRP (a protein linked to migraines) can safely trigger a migraine with aura in people who already have this condition. You'll receive an infusion and be monitored to see how your body responds.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
This study tests whether giving a substance called PACAP38 can trigger a migraine with aura in a controlled setting. It helps understand the causes of migraines and may lead to better treatments.
This trial tests a special type of acupuncture called Fu's Subcutaneous Needling to see if it can help reduce migraine attacks. It compares this treatment to a standard medication to find out which works better.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
Hear when a new Migraine With Aura trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.